Skip to main content
. Author manuscript; available in PMC: 2020 May 28.
Published in final edited form as: Cancer Res. 2009 Jan 1;69(1):161–170. doi: 10.1158/0008-5472.CAN-08-0835

Table 2.

Logistic regression analyses of components in IGFs/IGF-IR system in relation to the sensitivity to IGF-IR inhibitor BMS-536924

Gene P Odds ratio* (95% CI) AUC
IGF-I 0.039 2.86 (0.08–0.96) 0.67
IGF-II 0.062 2.27 (0.13–1.04) 0.63
IGF-I + IGF-II 0.0004 4.76 (0.07–0.62) 0.87
IGF-IR 0.011 3.45 (0.07–0.78) 0.8
IGFBP-3 0.006 0.27 (1.39–14.58) 0.75
IGFBP-6 6.79E–06 0.07 (3.45–150.88) 0.91
Insulin 0.556 1.26 (0.58–2.98) 0.53
IR 0.1094 1.94 (0.87–5.08) 0.75

Abbreviations: 95% CI, 95% confidence interval; AUC, area under the receiver operating characteristic curve; IR, insulin receptor.

*

For odds of BMS-536924–sensitive versus resistant cell line groups, as defined in Table 1.

HHS Vulnerability Disclosure